Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019079 (
hemoptysis
)
6,129
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Although the internal cardioverter defibrillator has prevented many premature deaths from lethal ventricular arrhythmias, some complications have occurred with its use. We present a patient who developed a fistula between the left ventricle and a bronchus, caused by erosion of the ventricular patch. The patient's presenting symptom was
hemoptysis
. Physicians caring for patients with these devices should be aware of this potential problem.
J
Cardiovasc
Electrophysiol 1994 Nov
PMID:Implantable cardioverter defibrillator patch erosion presenting as hemoptysis. 788 35
Alveolar hemorrhage is an entity caused by different etiologies. We report the case of a male who was admitted in our Service due to
hemoptysis
secondary to an alveolar hemorrhage diagnosed by chest X-ray and fiberoptic bronchoscopy. Thirty six hours after the admission the patient died and his necropsy showed dissection of ascending aorta and alveolar hemorrhage.
J
Cardiovasc
Surg (Torino) 1994 Aug
PMID:Dissection of ascending aorta. A new cause of alveolar hemorrhage? 792 46
A 25-year-old man suffering from sudden onset of
haemoptysis
after 1 week of orthopnoea, fatigue and general weakness was admitted to a cardiology department in Vienna. No diagnosis was made. Four weeks later cardiopulmonary resuscitation and pericardiocentesis were necessary because of cardiac tamponade. Although all modern imaging procedures were performed, a diagnosis of rapidly progressive primary cardiac angiosarcoma could not be established. Definitive diagnosis was established only after exploratory median sternotomy. The patient exhibited no response to chemotherapy. He died 5 days after surgery as a result of respiratory failure.
Cardiovasc
Surg 1993 Dec
PMID:Cardiac angiosarcoma--a diagnostic dilemma. 807 21
A case of pulmonary leiomyosarcoma originating in the left pulmonary artery stem in a 28-year-old Japanese man is reported. The patient complained of recurrent
hemoptysis
. The diagnosis was made at exploratory thoracotomy. Two days following thoracotomy, under cardio-pulmonary bypass, the upper one-third of the pulmonary trunk and part of the right pulmonary artery stem were resected and left pneumonectomy was performed. A Dacron prosthetic 23 mm composite graft was inserted to replace the pulmonary trunk and a portion of the right pulmonary artery. Postoperative course was uneventful. The patient died about 8 months after surgery because of right lung metastases. In our review of surgically treated forty-eight cases, complete resection was performed in 11, incomplete resection in 23, and embolectomy in 6, whereas 8 were unresectable. A localisation often not allowing adequate resection of the tumor or the advanced stage of the tumor at surgery are considered the main causes of the poor prognosis of the pulmonary sarcoma.
Thorac
Cardiovasc
Surg 1994 Feb
PMID:Primary pulmonary-artery sarcoma. Report of a case with complete resection and graft replacement, and review of 47 surgically treated cases reported in the literature. 818 99
We present a 44-year-old woman in whom a bronchial-to-coronary artery communication via the conus branch was discovered after distal bronchial artery embolization with gelatin sponge for
hemoptysis
. If this bronchial-to-coronary artery anastomosis, not visible prior to embolization, had been inadvertently embolized, the patient could have developed a myocardial infarction. To reduce the likelihood of a serious complication, the possibility of this anastomosis should be kept in mind and angiography should be repeated before attempting proximal bronchial artery embolization.
Cardiovasc
Intervent Radiol
PMID:Visualization of left bronchial-to-coronary artery communication after distal bronchial artery embolization for bronchiectasis. 818 31
A 24-year-old woman with catamenial
haemoptysis
was treated with the antioestrogenic drug danazol for suspected pulmonary endometriosis. The
haemoptysis
then ceased, but rapidly recurred when the patient discontinued the medication 3 months later because of severe side effects. Lobectomy was performed, and the diagnosis histologically confirmed, 14 months after the onset of symptoms. Thereafter the patient was free from
haemoptysis
.
Scand J Thorac
Cardiovasc
Surg 1993
PMID:Pulmonary endometriosis causing haemoptysis. Report of a case treated with lobectomy. 821 Oct 6
A 23-year-old man had been coughing with
hemoptysis
, and had received tuberculostatic medication for four months without any benefit. Upon referral, two-dimensional echocardiography showed a cystic mass located in the anterior right-ventricular wall, without any protrusion into the ventricular cavity. CT examination revealed three cysts in the lung fields bilaterally, additionally a multilocular cystic image in the right-ventricular wall was observed. All components of hydatid cysts in the heart and lungs were removed in the same session by median sternotomy. Extracorporeal bypass was used in this operation.
Thorac
Cardiovasc
Surg 1993 Aug
PMID:A case of cardiac hydatid cyst localized in the lungs bilaterally and on anterior wall of right ventricle. 821 34
We describe a case of massive
hemoptysis
, secondary to an intracavitary aspergilloma, successfully treated by computed tomography (CT)-guided placement of a Cope-loop catheter with daily transcatheter instillation of amphotericin B and cavitary irrigation. Over a 15-day period, this regimen resulted in cessation of
hemoptysis
and radiographic resolution of the aspergilloma. No complications were encountered. A follow-up CT of the thorax showed no recurrence of the aspergilloma at 3 months.
Cardiovasc
Intervent Radiol
PMID:Percutaneous transcatheter treatment of an intracavitary aspergilloma. 826 32
Between 6/87 and 3/92 22 out of 24 patients were treated (22 by surgery) for pulmonary and pleural Aspergillus disease. The most frequent lung disorder was tuberculosis (9 x), followed by bronchiectasis (5 x), congenital lung cysts (2 x), pneumonia with abscess formation (2 x), sarcoidosis (2 x), and bronchial cancer (4 x). More than half the patients had further severe secondary diseases. 4 patients with "simple aspergilloma" and 5 patients with "complex aspergilloma" underwent lobectomy or segmentectomy without complications or recurrence. Special surgical problems occurred in 13 patients with inflammation involving pleura and chest wall (pleuro-pulmonary aspergillosis, pleural aspergillosis) and invasive lung changes (invasive pulmonary aspergillosis). 7 patients developed an empyema after lung resection, on 4 occasions with bronchopleural fistula. In 4 cases myoplasty, in 2 cases thoracomyoplasty, on 2 occasions completion pneumonectomy with omentoplasty, in one case omentoplasty alone, and on 2 occasions decortication with pleurectomy and lung resection lead to a complete cure. 2 open window thoracostomies were constructed. In 15 cases a single operation was adequate. In 7 patients up to 3 further operations were necessary. 17 patients had
haemoptysis
, in 10 of these cases it was recurrent. On 7 occasions life-threatening haemorrhage took place, causing death in 2 cases. These were the only deaths resulting from the lung disease. Our results show that aggressive surgical action can be successful. Myoplasty, thoracomyoplasty, and omentoplasty are, in our view, the most suitable measures for healing pleura empyemas and bronchopleural fistulae coincident with pleuro-pulmonary aspergillosis.(ABSTRACT TRUNCATED AT 250 WORDS)
Thorac
Cardiovasc
Surg 1993 Feb
PMID:Surgical treatment of pulmonary and pleuro-pulmonary Aspergillus disease. 836 59
A retrospective analysis was done of 120 consecutive patients with life-threatening
hemoptysis
(greater than 200 ml of discharge per 24 hours) cared for between 1983 and 1990 at our institution. Seventy-nine percent of the patients (95/120) had
hemoptysis
exceeding 500 ml/24 hr. Inflammatory lung disease was the underlying cause in at least 85% of cases (n = 103); and of these, pulmonary tuberculosis was the primary diagnosis in 85% (88/103). Fifty-two patients (43%) had had a prior episode of massive
hemoptysis
, usually within 3 months of their admission. Urgent examination with rigid endoscope in 97 patients (81%) localized the bleeding in only 42 (43%). The overall hospital mortality rate was 10% (12/120) and was similar for those having pulmonary resection (7.1%, 3/42), and those assisted medically (11.5%, 9/78) (p = not significant). However, of these hospital survivors on whom 6-month follow-up was available, 36.4% (20/55) of those with medical management and none (0/39) (p < 0.001) of those with surgical management had recurrent massive
hemoptysis
. Forty-five percent of these cases were fatal. Current management of massive
hemoptysis
has resulted in improved hospital outcome. However, the high risk of recurrent and often fatal
hemoptysis
mandates the definitive management of the bronchial arteries before discharge from the hospital. Recent reports suggest that percutaneous embolization may be effective in nonsurgical candidates.
J Thorac
Cardiovasc
Surg 1993 Mar
PMID:Management and prognosis of massive hemoptysis. Recent experience with 120 patients. 844 18
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>